Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$6.2 - $9.34 $648,272 - $976,590
-104,560 Reduced 13.09%
694,358 $4.87 Million
Q2 2023

Aug 14, 2023

BUY
$8.76 - $11.92 $320,659 - $436,331
36,605 Added 4.8%
798,918 $7.37 Million
Q1 2023

May 15, 2023

SELL
$10.44 - $12.49 $282,245 - $337,667
-27,035 Reduced 3.42%
762,313 $8.44 Million
Q4 2022

Feb 14, 2023

SELL
$8.01 - $11.35 $83,960 - $118,970
-10,482 Reduced 1.31%
789,348 $8.41 Million
Q3 2022

Nov 14, 2022

BUY
$6.25 - $8.94 $5 Million - $7.15 Million
799,830 New
799,830 $6.6 Million
Q3 2021

Nov 15, 2021

SELL
$5.52 - $6.97 $1.1 Million - $1.39 Million
-200,000 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$5.88 - $9.54 $1.18 Million - $1.91 Million
200,000 New
200,000 $1.42 Million

Others Institutions Holding EDAP

About EDAP TMS SA


  • Ticker EDAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,145,300
  • Market Cap $88.6M
  • Description
  • EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWav...
More about EDAP
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.